KRON

Kronos Bio
KRON

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

KRON was delisted on the 20th of June, 2025.

Back to rankings
 

About: Kronos Bio Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of small molecule therapeutics to address deregulated transcription, a hallmark of cancer and autoimmune diseases.

Employees: 8

Healthcare Biotechnology
Price charts implemented using Lightweight Charts™